dc.contributor.author | Villarreal, Alcibiades E. | |
dc.contributor.author | Barron, Rachel | |
dc.contributor.author | Rao, KS Jagannatha | |
dc.contributor.author | Britton, Gabrielle B. | |
dc.date.accessioned | 2020-07-03T21:40:33Z | |
dc.date.available | 2020-07-03T21:40:33Z | |
dc.date.issued | 2014-01-01 | |
dc.identifier.other | 10.3233/JAD-140144 | |
dc.identifier.uri | http://repositorio-indicasat.org.pa/handle/123456789/167 | |
dc.description | Persistent systemic hypoxia, a direct consequence of alterations in vascular function, can compromise the brain by
increasing the risk of developing dementias such as Alzheimer’s disease (AD). Vascular contributions to cognitive impairment
and AD in aged individuals are common, and several vascular risk factors for AD are linked to hypoxia. Clinical evidence
confirms that structural and functional changes characteristic of AD pathology also occur following hypoxic-ischemic events
such as stroke and traumatic brain injury. Studies with transgenic and non-transgenic mouse models reliably show that hypoxia
increases the levels of amyloid- peptides that form the characteristic plaques in AD brains. Moreover, some studies suggest that
vascular lesions also promote tau phosphorylation, modulate apolipoprotein E expression, and have more profound in effects in
aged animals, but additional evidence is needed to establish these findings. Although the mechanisms underlying hypoxia-related
effects remain unclear, controlled animal studies continue to reveal mechanistic aspects of the relationship between hypoxia and
AD pathology that are necessary for therapeutic developments. The present review summarizes evidence from rodent studies
regarding the effects of hypoxia on AD-related pathology and evaluates its impact on understanding human disease. | en_US |
dc.description.abstract | Persistent systemic hypoxia, a direct consequence of alterations in vascular function, can compromise the brain by
increasing the risk of developing dementias such as Alzheimer’s disease (AD). Vascular contributions to cognitive impairment
and AD in aged individuals are common, and several vascular risk factors for AD are linked to hypoxia. Clinical evidence
confirms that structural and functional changes characteristic of AD pathology also occur following hypoxic-ischemic events
such as stroke and traumatic brain injury. Studies with transgenic and non-transgenic mouse models reliably show that hypoxia
increases the levels of amyloid- peptides that form the characteristic plaques in AD brains. Moreover, some studies suggest that
vascular lesions also promote tau phosphorylation, modulate apolipoprotein E expression, and have more profound in effects in
aged animals, but additional evidence is needed to establish these findings. Although the mechanisms underlying hypoxia-related
effects remain unclear, controlled animal studies continue to reveal mechanistic aspects of the relationship between hypoxia and
AD pathology that are necessary for therapeutic developments. The present review summarizes evidence from rodent studies
regarding the effects of hypoxia on AD-related pathology and evaluates its impact on understanding human disease. | en_US |
dc.language.iso | en | en_US |
dc.subject | Amyloid- | en_US |
dc.subject | apolipoprotein E | en_US |
dc.subject | cerebral amyloid angiopathy | en_US |
dc.subject | cerebral hypoxia | en_US |
dc.subject | ischemia | en_US |
dc.subject | tau protein | en_US |
dc.title | The effects of impaired cerebral circulation on Alzheimer's disease pathology: evidence from animal studies. | en_US |
dc.type | Article | en_US |